Megan Escott
Papers
1
Total Citations
3
H-Index
1
About
Dr. Megan Escott is a rising surgical oncologist whose work is reshaping the management of upper tract urothelial carcinoma (UTUC). Her research focuses on the comparative effectiveness of surgical approaches—specifically open, laparoscopic, and robotic radical nephroureterectomy—with a keen eye on both oncologic outcomes and health economics. In her landmark 2025 study, Dr. Escott rigorously compared these three modalities, introducing the novel "tetrafecta" as a composite outcome measure to holistically assess surgical success. This work, already garnering 3 citations, provides critical evidence for optimizing patient outcomes while controlling healthcare costs. By demonstrating the nuanced trade-offs between minimally invasive techniques and traditional open surgery, Dr. Escott is helping to define best practices in urologic oncology. Her contributions are particularly valuable for surgeons and trainees navigating the rapidly evolving landscape of robotic surgery, offering data-driven guidance for complex clinical decisions. As her citation profile grows, Dr. Escott is establishing herself as a thoughtful voice in evidence-based surgical innovation.
Research Focus
Key Achievements
Top Papers
- 1